Hematopoietic cell transplantation in inherited bone marrow failure syndromes
DOI:
https://doi.org/10.46765/2675-374X.2025v6n1e288Keywords:
Hematopoietic Stem Cell Transplantation, Congenital Bone Marrow Failure Syndromes, Fanconi Anemia, Dyskeratosis Congenita, AnemiaAbstract
Inherited bone marrow failure syndromes (IBMFS) comprise a heterogeneous group of rare genetic disorders characterized by defective hematopoiesis, congenital anomalies, and a predisposition to clonal evolution and malignancies. Hematopoietic cell transplantation remains the only curative option for the hematologic manifestations of these disorders, although it does not correct congenital malformations or eliminate the long-term risk of non-hematopoietic cancers. This review summarized current evidence and transplantation strategies for major IBMFS, including Fanconi anemia, dyskeratosis congenita/telomere biology disorders, Diamond-Blackfan anemia, Shwachman-Diamond syndrome, congenital neutropenia, congenital amegakaryocytic thrombocytopenia, and other inherited thrombocytopenias. We discussed disease-specific transplant indications, donor selection, conditioning regimens, graft source preferences, and outcomes across different patient populations. Advances in reduced-intensity conditioning and post-transplant cyclophosphamide have expanded donor availability, improving survival even with alternative donors. Nevertheless, long-term challenges persist, such as increased risks of solid tumors, endocrine dysfunction, and organ toxicity, emphasizing the need for multidisciplinary care and lifelong surveillance. Optimal outcomes depend on timely referral to specialized centers, meticulous donor screening, and individualized transplant strategies tailored to the unique biology of each disorder.
References
1. Alter BP. Inherited bone marrow failure syndromes: considerations pre- and posttransplant. Blood. 2017 3;130(21):2257–64. https://doi.org/10.1182/blood-2017-05-781799 DOI: https://doi.org/10.1182/blood-2017-05-781799
2. Dokal I, Tummala H, Vulliamy T. Inherited bone marrow failure in the pediatric patient. Blood. 2022;140(6):556–70. https://doi.org/10.1182/blood.2020006481 DOI: https://doi.org/10.1182/blood.2020006481
3. Bluteau O, Sebert M, Leblanc T, Peffault de Latour R, Quentin S, Lainey E, Hernandez L, Dalle JH, Sicre de Fontbrune F, Lengline E, Itzykson R, Clappier E, Boissel N, Vasquez N, Da Costa M, Masliah-Planchon J, Cuccuini W, Raimbault A, De Jaegere L, Adès L, Fenaux P, Maury S, Schmitt C, Muller M, Domenech C, Blin N, Bruno B, Pellier I, Hunault M, Blanche S, Petit A, Leverger G, Michel G, Bertrand Y, Baruchel A, Socié G, Soulier J. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients. Blood. 2018;131(7):717–32. https://doi.org/10.1182/blood-2017-09-806489 DOI: https://doi.org/10.1182/blood-2017-09-806489
4. Bonfim C. Special pre- and posttransplant considerations in inherited bone marrow failure and hematopoietic malignancy predisposition syndromes. Hematology. 2020;2020(1):107–14. https://doi.org/10.1182/hematology.2020000095 DOI: https://doi.org/10.1182/hematology.2020000095
5. Sakaguchi H, Yoshida N. Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes. Int J Hematol. 2022;116(1):16–27. https://doi.org/10.1007/s12185-022-03362-4 DOI: https://doi.org/10.1007/s12185-022-03362-4
6. Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica. 2018;103(1):30–9. https://doi.org/10.3324/haematol.2017.178111 DOI: https://doi.org/10.3324/haematol.2017.178111
7. Calado RT, Clé DV. Treatment of inherited bone marrow failure syndromes beyond transplantation. Hematology. 2017;2017(1):96–101. https://doi.org/10.1182/asheducation-2017.1.96 DOI: https://doi.org/10.1182/asheducation-2017.1.96
8. Peake JD, Noguchi E. Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair. Hum Genet. 2022;141(12):1811–36. https://doi.org/10.1007/s00439-022-02462-9 DOI: https://doi.org/10.1007/s00439-022-02462-9
9. Dufour C, Pierri F. Modern management of Fanconi anemia. Hematology. 2022;2022(1):649–57. https://doi.org/10.1182/hematology.2022000393 DOI: https://doi.org/10.1182/hematology.2022000393
10. Debureaux PE, Sicre de Fontbrune F, Bonfim C, Dalle JH, Buchbinder N, Bertrand Y, Renard C, Forcade E, Fernandes J, Talbot A, Pasquini R, Soulier J, Leblanc T, Socie G, Peffault de Latour R. FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study. Bone Marrow Transplant. 2021;56(1):285–8. https://doi.org/10.1038/s41409-020-0994-2 DOI: https://doi.org/10.1038/s41409-020-0994-2
11. Lum SH, Eikema DJ, Piepenbroek B, Wynn RF, Samarasinghe S, Dalissier A, Kalwak K, Ayas M, Hamladji RM, Yesilipek A, Dalle JH, Uckan-Cetinkaya D, Bierings M, Kupesiz A, Halahleh K, Skorobogatova E, Öztürk G, Faraci M, Renard C, Evans P, Corbacioglu S, Locatelli F, Dufour C, Risitano A, Peffault de Latour R. Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia. Blood. 2024;144(12):1329–42. https://doi.org/10.1182/blood.2023022751 DOI: https://doi.org/10.1182/blood.2023022751
12. Cancio M, Troullioud Lucas AG, Bierings M, Klein E, de Witte MA, Smiers FJ, Bresters D, Boelens JJ, Smetsers SE. Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia. Bone Marrow Transplant. 2024;59(1):34–40. https://doi.org/10.1038/s41409-023-02121-1 DOI: https://doi.org/10.1038/s41409-023-02121-1
13. Bonfim C, Nichele S, Loth G, Funke VAM, Nabhan SK, Pillonetto DV, Lima ACM, Pasquini R. Transplantation for Fanconi anaemia: lessons learned from Brazil. The Lancet Haematology. 2022;9(3):e228–36. https://doi.org/10.1016/s2352-3026(22)00032-1 DOI: https://doi.org/10.1016/S2352-3026(22)00032-1
14. Bonfim C, Ribeiro L, Nichele S, Bitencourt M, Loth G, Koliski A, Funke VAM, Pilonetto DV, Pereira NF, Flowers MED, Velleuer E, Dietrich R, Fasth A, Torres-Pereira CC, Pedruzzi P, Eapen M, Pasquini R. Long term survival, organ function, and malignancy after hematopoietic stem cell transplantation for Fanconi anemia. Biol Blood Marrow Transplant. 2016;22(7):1257–63. https://doi.org/10.1016/j.bbmt.2016.03.007 DOI: https://doi.org/10.1016/j.bbmt.2016.03.007
15. Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010;24(3):101–22. https://doi.org/10.1016/j.blre.2010.03.002 DOI: https://doi.org/10.1016/j.blre.2010.03.002
16. MacMillan ML, DeFor TE, Young JA, Dusenbery KE, Blazar BR, Slungaard A, Zierhut H, Weisdorf DJ, Wagner JE. Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood. 2015;125(24):3798–804. https://doi.org/10.1182/blood-2015-02-626002 DOI: https://doi.org/10.1182/blood-2015-02-626002
17. Agarwal S. Evaluation and management of hematopoietic failure in dyskeratosis congenita. Hematol Oncol Clin North Am. 2018;32(4):669–85. https://doi.org/10.1016/j.hoc.2018.04.003 DOI: https://doi.org/10.1016/j.hoc.2018.04.003
18. Savage SA. Dyskeratosis congenita and telomere biology disorders. Hematology Am Soc Hematol Educ Program. 2022;2022(1):637–48. https://doi.org/10.1182/hematology.2022000394 DOI: https://doi.org/10.1182/hematology.2022000394
19. Niewisch MR, Giri N, McReynolds LJ, Alsaggaf R, Bhala S, Alter BP, Savage SA. Disease progression and clinical outcomes in telomere biology disorders. Blood. 2022;139(12):1807–19. https://doi.org/10.1182/blood.2021013523 DOI: https://doi.org/10.1182/blood.2021013523
20. Bhoopalan SV, Wlodarski M, Reiss U, Triplett B, Sharma A. Reduced‐intensity conditioning–based hematopoietic cell transplantation for dyskeratosis congenita: Single‐center experience and literature review. Pediatr Blood Cancer. 2021;68(10):e29177. https://doi.org/10.1002/pbc.29177 DOI: https://doi.org/10.1002/pbc.29177
21. Nichele S, Bonfim C, Junior LGD, Loth G, Kuwahara C, Trennephol J, Funke VAM, Marinho DE, Koliski A, Rodrigues AM, Mousquer RTG, Fasth A, Lima ACM, Calado RT, Pasquini R. Hematopoietic cell transplantation for telomere biology diseases: A retrospective single-center cohort study. Eur J Haematol. 2023;111(3):423–31. https://doi.org/10.1111/ejh.14023 DOI: https://doi.org/10.1111/ejh.14023
22. Fioredda F, Iacobelli S, Korthof ET, Knol C, van Biezen A, Bresters D, Veys P, Yoshimi A, Fagioli F, Mats B, Zecca M, Faraci M, Miano M, Arcuri L, Maschan M, O’Brien T, Diaz MA, Sevilla J, Smith O, Peffault de Latour R, de la Fuente J, Or R, Van Lint MT, Tolar J, Aljurf M, Fisher A, Skorobogatova EV, Diaz de Heredia C, Risitano A, Dalle JH, Sedláček P, Ghavamzadeh A, Dufour C. Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita. Br J Haematol. 2018;183(1):110–8. https://doi.org/10.1111/bjh.15495 DOI: https://doi.org/10.1111/bjh.15495
23. Rolles B, Tometten M, Meyer R, Kirschner M, Beier F, Brümmendorf TH. Inherited telomere biology disorders: pathophysiology, clinical presentation, diagnostics, and treatment. Transfus Med Hemother. 2024;51(5):292–309. https://doi.org/10.1159/000540109 DOI: https://doi.org/10.1159/000540109
24. Costa L, Leblanc T, Mohandas N. Diamond-Blackfan anemia. Blood. 2020;136(11):1262–73. https://doi.org/10.1182/blood.2019000947 DOI: https://doi.org/10.1182/blood.2019000947
25. Wlodarski MW, Vlachos A, Farrar JE, Da Costa LM, Kattamis A, Dianzani I, Belendez C, Unal S, Tamary H, Pasauliene R, Pospisilova D, de la Fuente J, Iskander D, Wolfe L, Liu JM, Shimamura A, Albrecht K, Lausen B, Bechensteen AG, Tedgard U, Puzik A, Quarello P, Ramenghi U, Bartels M, Hengartner H, Farah RA, Al Saleh M, Hamidieh AA, Yang W, Ito E, Kook H, Ovsyannikova G, Kager L, Gleizes PE, Dalle JH, Strahm B, Niemeyer CM, Lipton JM, Leblanc TM; international Diamond-Blackfan anaemia syndrome guideline panel. Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement. Lancet Haematol. 2024;11(5):e368–e382. https://doi.org/10.1016/S2352-3026(24)00063-2 DOI: https://doi.org/10.1016/S2352-3026(24)00063-2
26. Darrigo LG Junior, Loth G, Kuwahara C, Vieira A, Colturato V, Rodrigues AL, Arcuri L, Fernandes J, Macedo A, Tavares R, Gomes A, Ribeiro L, Seber A, Zecchin V, de Souza M, Calixto R, Pasquini R, Flowers M, Rocha V, Bonfim C. Hematopoietic cell transplantation for Diamond Blackfan anemia: A report from the Pediatric Group of the Brazilian Bone Marrow Transplantation Society. Eur J Haematol. 2020;105(4):426–33. https://doi.org/10.1111/ejh.13463 DOI: https://doi.org/10.1111/ejh.13463
27. Strahm B, Loewecke F, Niemeyer CM, Albert M, Ansari M, Bader P, Bertrand Y, Burkhardt B, Da Costa LM, Ferster A, Fischer A, Güngör T, Gruhn B, Hainmann I, Kapp F, Lang P, Müller I, Schulz A, Szvetnik A, Wlodarski M, Noellke P, Leblanc T, Dalle JH. Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemia. Blood Adv. 2020;4(8):1760–9. https://doi.org/10.1182/bloodadvances.2019001210 DOI: https://doi.org/10.1182/bloodadvances.2019001210
28. Cesaro S, Donadieu J, Cipolli M, Dalle JH, Styczynski J, Masetti R, Strahm B, Mauro M, Alseraihy A, Aljurf M, Dufour C, de la Tour RP. Stem cell transplantation in patients affected by Shwachman-Diamond Syndrome: Expert Consensus and Recommendations From the EBMT Severe Aplastic Anaemia Working Party. Transplant Cell Ther. 2022;28(10):637–49. https://doi.org/10.1016/j.jtct.2022.07.010 DOI: https://doi.org/10.1016/j.jtct.2022.07.010
29. Myers KC, Furutani E, Weller E, Siegele B, Galvin A, Arsenault V, Alter BP, Boulad F, Bueso-Ramos C, Burroughs L, Castillo P, Connelly J, Davies SM, DiNardo CD, Hanif I, Ho RH, Karras N, Manalang M, McReynolds LJ, Nakano TA, Nalepa G, Norkin M, Oberley MJ, Orgel E, Pastore YD, Rosenthal J, Walkovich K, Larson J, Malsch M, Elghetany MT, Fleming MD, Shimamura A. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study. Lancet Haematol. 2020;7(3):e238–46. https://doi.org/10.1016/S2352-3026(19)30206-6 DOI: https://doi.org/10.1016/S2352-3026(19)30206-6
30. Cesaro S, Pillon M, Sauer M, Smiers F, Faraci M, de Heredia CD, Wynn R, Greil J, Locatelli F, Veys P, Uyttebroeck A, Ljungman P, Chevalier P, Ansari M, Badell I, Güngör T, Salim R, Tischer J, Tecchio C, Russell N, Chybicka A, Styczynski J, Krivan G, Smith O, Stein J, Afanasyev B, Pochon C, Menconi MC, Bosman P, Mauro M, Tridello G, de Latour RP, Dufour C. Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT). Bone Marrow Transplant. 2020;55(9):1796–809. https://doi.org/10.1038/s41409-020-0863-z. Epub 2020 Mar 19. Erratum in: Bone Marrow Transplant. 2020;55(9):1884. https://doi.org/10.1038/s41409-020-0901-x DOI: https://doi.org/10.1038/s41409-020-0863-z
31. Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers. 2017;3:17032. https://doi.org/10.1038/nrdp.2017.32 DOI: https://doi.org/10.1038/nrdp.2017.32
32. Sureda A, Corbacioglu S, Greco R, Kröger N, Carreras E, editores. The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies. Cham: Springer International; 2024. https://doi.org/10.1007/978-3-031-44080-9 DOI: https://doi.org/10.1007/978-3-031-44080-9
33. Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr Opin Hematol. 2012;19(1):44–51. https://doi.org/10.1097/moh.0b013e32834da96e DOI: https://doi.org/10.1097/MOH.0b013e32834da96e
34. Giardino S, Eikema DJ, Piepenbroek B, Algeri M, Ayas M, Faraci M, Tbakhi A, Zecca M, Essa M, Neven B, Bertrand Y, Kharya G, Bykova T, Lawson S, Petrini M, Mohseny A, Rialland F, James B, Colita A, Fahd M, Cesaro S, Schulz A, Kleinschmidt K, Kałwak K, Corbacioglu S, Dufour C, Risitano A, de Latour RP. HLAhaploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties. Am J Hematol. 2024;99(6):1066–76. https://doi.org/10.1002/ajh.27293 DOI: https://doi.org/10.1002/ajh.27293
35. Oved JH, Gibson NM, Venella K, Elgarten CW, Wray L, Warren JT, Olson TS. Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. Front Immunol. 2024;15:1369243. https://doi.org/10.3389/fimmu.2024.1369243 DOI: https://doi.org/10.3389/fimmu.2024.1369243
36. Ballmaier M, Germeshausen M. Advances in the understanding of congenital amegakaryocytic thrombocytopenia. Br J Haematol. 2009;146(1):3–16. https://doi.org/10.1111/j.1365-2141.2009.07706.x DOI: https://doi.org/10.1111/j.1365-2141.2009.07706.x
37. Germeshausen M, Ballmaier M. CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients. Haematologica. 2021;106(9):2439–48. https://doi.org/10.3324/haematol.2020.257972 DOI: https://doi.org/10.3324/haematol.2020.257972
38. Germeshausen M, Ballmaier M. Congenital amegakaryocytic thrombocytopenia - Not a single disease. Best Pract Res Clin Haematol. 2021;34(2):101286. https://doi.org/10.1016/j.beha.2021.101286 DOI: https://doi.org/10.1016/j.beha.2021.101286
39. Geddis AE. Congenital amegakaryocytic thrombocytopenia. Pediatr Blood Cancer. 2011;57(2):199–203. https://doi.org/10.1002/pbc.22927 DOI: https://doi.org/10.1002/pbc.22927
40. Aldebert C, Fahd M, Galimard JE, Ghemlas IA, Zecca M, Silva J, Mohseny A, Kupesiz A, Hamladji RM, Miranda N, Güngör T, Wynn RF, Merli P, Sundin M, Faraci M, Diaz-de-Heredia C, Burkhardt B, Bordon V, Angoso M, Bader P, Ifversen M, Herrera Arroyo C, Maximova N, Riesco S, Stein J, Dalissier A, Locatelli F, Kalwak K, Dalle JH, Corbacioglu S. Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT. Bone Marrow Transplant. 2024;59(12):1717–25. https://doi.org/10.1038/s41409-024-02416-x DOI: https://doi.org/10.1038/s41409-024-02416-x
41. Pecci A, Balduini CL. Inherited thrombocytopenias: an updated guide for clinicians. Blood Rev. 2021;48:100784. https://doi.org/10.1016/j.blre.2020.100784 DOI: https://doi.org/10.1016/j.blre.2020.100784
42. Cancio M, Hebert K, Kim S, Aljurf M, Olson T, Anderson E, Burroughs L, Vatsayan A, Myers K, Hashem
H, Hanna R, Horn B, Prestidge T, Boelens JJ, Boulad F, Eapen M. Outcomes in hematopoietic stem cell
transplantation for congenital amegakaryocytic thrombocytopenia. Transplant Cell Ther. 2022;28(2):101. e1–e6. https://doi.org/10.1016/j.jtct.2021.10.009 DOI: https://doi.org/10.1016/j.jtct.2021.10.009
43. Consensus Guidelines for pediatric hematopoietic stem cell transplantation from Brazilian Society for Blood and Marrow Transplantation and Cellular Therapy. JBMTCT. 2021;2(4). https://doi.org/10.46765/2675-374X.2021v2n4 DOI: https://doi.org/10.46765/2675-374X.2021v2n4
44. Loth G, Dumke CCK, Muratori RR, Pelegrina PD, Peixoto CMA, Bach JLM, Nichele S, Trennepohl JP, Koliski A, Mousquer RTG, Rodrigues AM, Marchesini R, Feitosa MK, Pilonetto DV, Gouvea L, Benini FML, Pirolli ES, Tutumi RAF, Lima ACM, Pasquini R, Bonfim C. Haematopoietic cell transplantation for 106 infants and preschoolers with acquired and inherited bone marrow failures. Br J Haematol. 2024;205(6):2387–402.https://doi.org/10.1111/bjh.19831 DOI: https://doi.org/10.1111/bjh.19831
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Gisele Loth, Luiz Guilherme Darrigo, Adriana Martins, Alexandre de Albuquerque Antunes, Ana Karine Vieira

This work is licensed under a Creative Commons Attribution 4.0 International License.